Phanes Therapeutics is a clinical-stage biotechnology company focused on innovative drug discovery and development in oncology. Recently expanded its clinical trial collaboration with Merck to evaluate spevatamig in combination with KEYTRUDA for biliary tract cancer.
Phase 2 interim readout
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology,...
Phanes Therapeutics expanded its clinical trial collaboration with Merck to evaluate spevatamig in combination with KEYTRUDA for biliary tract cancer.
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer